A federal judge has issued a ruling that sides with the Federal Trade Commission’s rules regarding pharmaceutical patents, according to reports.

The Pharmaceutical Research and Manufacturers of America launched a legal challenge to the FTC’s 2013 Hart-Scott-Rodino Antitrust Improvements Act addition, which required two types of patent transfers within the pharmaceutical …read more

Source: Global Competition Law Blogs